A blood test given to an expectant mother between weeks 15 and 18 of pregnancy to screen for an increased risk of the baby having a birth defect. High levels of AFP may be associated with a neural tube defect; low levels may be associated with Down syndrome. The test is used to decide whether more invasive testing, such as an amniocentesis, is necessary.